Christopher Ryan Sullivan sold $1.5M of Avalo Therapeutics, Inc. (AVTX) stock

Christopher Ryan Sullivan, Chief Financial Officer of Avalo Therapeutics, Inc. (AVTX), sold 72,725 shares of AVTX stock worth $1.5M, per an SEC Form 4 filed Aug 19, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 17, 2026, 2 days before it was made public.

AVTX has moved -17.2% since the trade date, from $19.95 to $16.51 (Sep 22, 2026 close).